Thuy excels in model-informed drug development, leveraging her keen understanding of clinical pharmacology and implementation of predictive models to guide strategic decision-making. With over 17 years of experience in pharmacometrics and clinical pharmacology and over 5 years in clinical research, Thuy has overseen the development of novel compounds across early and late phases and life cycle management, spanning diverse therapeutic areas. A member of ISoP, ASCPT, and Rho Chi Pharmacy Honor Society and author of 15 peer-reviewed publications, Thuy is an active member of the academic pharmaceutical community.